Urinary concentrating defect in experimental hemochromatosis

Journal of the American Society of Nephrology

Volumn 7, Issue 1, 1996, Pages 128-134

  Zhou, X J ^a   Vaziri, N D ^a,b   Pandian, D ^a   Wang, Z Q ^a   Mazowiecki, M ^a   Liao, S Y ^a   Oveisi, F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hemosiderosis; Iron overload; Osmolality; Renal sodium handling; Vasopressin

Indexed keywords

IRON DEXTRAN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEMOCHROMATOSIS; HEMOSIDEROSIS; IRON OVERLOAD; KIDNEY CONCENTRATING CAPACITY; MALE; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; RAT; SODIUM METABOLISM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030044834     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Edwards CQ, Griffen LM, Kushner JP: Disorders of excess iron. Hosp Pract (Off Ed) 1991;26[Suppl 3]:30-36.
2. Carthew P, Dorman BM, Edwards RE, Francis JE, Smith AG: A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest 1993;69:217-222.
3. Halliday CE, Halliday JW, Powell LW: The clinical manifestations of chronic iron overload. Baillieres Clin Haematol 1989;2:403-421.
4. Short EM, Winkle RA, Billingham ME: Myocardial involvement in idiopathic hemochromatosis: Morphologic and clinical improvement following venesection. Am J Med 1981;70:1275-1279.
5. Salonen JT, Nyyssonen K, Korpela H, Tamilehto J, Seppanen R, Salonen R: High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnishmen. Circulation 1992;86:803-811.
6. Iancu TC, Ward RJ, Peters TJ: Ultrastructural observations in the carbonyl iron-fed rat: An animal model for hemachromatosis. Virchows Arch B, Cell Pathol Incl Mol Pathol 1987;53:208-217.
7. Flynn DM, Hoffbrand AV, Politis D: Subcutaneous desferrioxamine: The effect of three years' treatment on liver iron, serum ferritin and comments on echocardiography. Birth Defects 1982;18:347-353.
8. Cohen A: Management of iron overload in the pediatric patient. Haematol Oncol Clin North Am 1987;1:521-544.
9. Herbert V: Everyone should be tested for iron disorders. J Am Diet Assoc 1992;92:1502-1509.
10. Mclaren GD, Muir WA, Kellermeyer RW: Iron overload disorders: Natural history, pathogenesis, diagnosis, and therapy. CRC Crit Rev Clin Lab Sci 1983;19:205-266.
11. De Sousa M: Immune cell functions in iron overload. Clin Exp Immunol 1989;75:1-6.
12. Galleano M, Farre SM, Turrens JF, Puntarulo S: Resistance of rat kidney mitochondrial membranes to oxidation induced by acute iron overload. Toxicology 1994;88: 141-149.
13. Masterangelo F, Lopez T, Rizzelli S, Manisco G, Corlia C, Alfonso L: Function of the kidney in adult patients with Cooley's disease. Nephron 1975;14:229-236.
14. Younes M, Ebezhard I, Lemoine E: Effect of iron overload on spontaneous and xenobiotic-induced lipid peroxidation in vivo. J Appl Toxicol 1989;9:103-108.
15. Golberg L, Martin LE, Batchelor A: Biochemical changes in the tissue of animals injected with iron: 3. Lipid peroxidation. Biochem J 1962;83:291-298.
16. Dillard CJ, Downey JE, Tappel AL: Effect of antioxidants on lipid peroxidation in iron loaded rats. Lipids 1984;19: 127-133.
17. Bankir L, DeRouffignac C: Urinary concentrating ability: Insights from comparative anatomy. Am J Physiol 1985; 219:R643-R666.
18. Skowsky WR, Rosenbloom AA, Fisher DA: Radioimmunoassay measurement of arginine vasopressin in serum. Development and application. J Clin Endocrinol Metab 1974;38:278-287.
19. Torrance JD, Bothwell TH: Tissue iron stores. In: Cook J, Ed. Iron. New York: Churchill Livingston; 1980:90-115.
20. Davidson WD, Sackner MA: Simplification of the anthrone method for the determination of insulin in clearance studies. J Lab Clin Med 1963;62:351-356.
21. Smith HW, Finklestein N, Aliminosah, Crawford B, Grabe M: The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945;24:388-404.
22. Ganguli M, Tobian L, Azar S, O'Donnell M: Evidence that prostaglandin synthesis inhibitors increase the concentration of sodium and chloride in rat renal medulla. Circ Res 1977;40[Suppl 1]:I135-I139.
23. Culpepper RM, Andreoli TE: Interactions among prostaglandin E2 antidiuretic hormone and cyclic adenos monophosphate in modulating CT transport in single mouse medullary thick ascending limbs of Henle. J Clin Invest 1983;71:1588-1601.
24. Quamme GA, Dirks JH: The physiology of renal magnesium handling. Renal Physiol 1986;9:257-269.
25. Borke JL, Penniston JT, Kumar R: Recent advances in calcium transport by the kidney. Semin Nephrol 1990; 10:15-23.
26. Landing BH, Gonick HC, Nadorra RL, et al.: Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis. Pediatr Pathol 1989;9:479-500.
27. Pardo-Mindan FJ, Diez J, Esparza N, Robledo C: Renal siderosis in patients with heart-valve prostheses: Clinical implications. Nephrol Dial Transplant 1990;5:847-850.
28. Bacon BR, Britton RS: Hepatic injury in chronic iron overload. Role of lipid peroxidation. Chem Biol Interact 1989;70:183-226.
29. Galleano M, Puntarulos S: Hepatic chemiluminescence and lipid peroxidation in mild iron overload. Toxicology 1992;76:27-38.
30. Britton RS, O'Neill R, Bacon BR: Chronic dietary iron overload in rats results in impaired calcium sequestration by hepatic mitochondria and microsomes 1,2, and 3. Gastroenterology 1991;101:806-811.